EP4522181A4 - Verwendung von natriumpentaboratpentahydrat als chemotherapeutikum - Google Patents

Verwendung von natriumpentaboratpentahydrat als chemotherapeutikum

Info

Publication number
EP4522181A4
EP4522181A4 EP23803950.7A EP23803950A EP4522181A4 EP 4522181 A4 EP4522181 A4 EP 4522181A4 EP 23803950 A EP23803950 A EP 23803950A EP 4522181 A4 EP4522181 A4 EP 4522181A4
Authority
EP
European Patent Office
Prior art keywords
chemotherapeutic
sodium pentaborate
pentaborate pentahydrate
pentahydrate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23803950.7A
Other languages
English (en)
French (fr)
Other versions
EP4522181A1 (de
Inventor
Fikrettin Sahin
Sesli Nezaket Turkel
Gulluoglu Sidika Tapsin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeditepe Universitesi
Original Assignee
Yeditepe Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeditepe Universitesi filed Critical Yeditepe Universitesi
Priority claimed from PCT/TR2023/050333 external-priority patent/WO2023219586A1/en
Publication of EP4522181A1 publication Critical patent/EP4522181A1/de
Publication of EP4522181A4 publication Critical patent/EP4522181A4/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP23803950.7A 2022-05-09 2023-04-10 Verwendung von natriumpentaboratpentahydrat als chemotherapeutikum Pending EP4522181A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202207524 2022-05-09
PCT/TR2023/050333 WO2023219586A1 (en) 2022-05-09 2023-04-10 Use of sodium pentaborate pentahydrate as a chemotherapeutic agent

Publications (2)

Publication Number Publication Date
EP4522181A1 EP4522181A1 (de) 2025-03-19
EP4522181A4 true EP4522181A4 (de) 2026-04-15

Family

ID=94686897

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23803950.7A Pending EP4522181A4 (de) 2022-05-09 2023-04-10 Verwendung von natriumpentaboratpentahydrat als chemotherapeutikum

Country Status (1)

Country Link
EP (1) EP4522181A4 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061711A1 (de) * 1981-03-27 1982-10-06 Heinrich Dr. Mückter 10B-carboxy-aminoborane, Verfahren zur Herstellung derselben sowie ihre Verwendung als Arzneimittel zur Neutroneneinfangtherapie

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061711A1 (de) * 1981-03-27 1982-10-06 Heinrich Dr. Mückter 10B-carboxy-aminoborane, Verfahren zur Herstellung derselben sowie ihre Verwendung als Arzneimittel zur Neutroneneinfangtherapie

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CEBECI EMRE ET AL: "Anti-cancer effect of boron derivatives on small-cell lung cancer", JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, FISCHER, NEW YORK, NY, US, vol. 70, 4 January 2022 (2022-01-04), XP086931386, ISSN: 0946-672X, [retrieved on 20220104], DOI: 10.1016/J.JTEMB.2022.126923 *
MATSUMOTO YOSHITAKA ET AL: "A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond", JOURNAL OF PERSONALIZED MEDICINE, vol. 11, no. 8, 23 August 2021 (2021-08-23), pages 1 - 32, XP093370847, ISSN: 2075-4426, DOI: 10.3390/jpm11080825 *
See also references of WO2023219586A1 *
TAPSIN ET AL: "Mechanism of Boron Derivatives for the Treatment of Renal Cell Carcinoma", 30 November 2013 (2013-11-30), XP009550749, Retrieved from the Internet <URL:https://tez.yok.gov.tr/UlusalTezMerkezi/tezDetay.jsp?id=mFBkvlbFNFJGzyQKqmrGHA&no=k--nz_G61Dp34ZJBAkrtJQ> [retrieved on 20260226] *

Also Published As

Publication number Publication date
EP4522181A1 (de) 2025-03-19

Similar Documents

Publication Publication Date Title
EP4556481A4 (de) Piperazinbrückensubstituierte heterocyclische pyrimidinverbindung
JP1749177S (ja) 時計用文字盤
EP4322956A4 (de) Verwendung von heterocyclischen erk1/inhibitoren2
EP4338302A4 (de) Vorkodierung von informationen
EP4055754C0 (de) Konfiguration von downlink-kontrollinformationsformaten
EP4508919C0 (de) Konfiguration mehrerer zeitvorlaufswerte
JP1736452S (ja) 時計用文字盤
EP4344477A4 (de) Verbesserte signalisierung von zusätzlichen erweiterungsinformationen
EP4370686A4 (de) Stöchiometrische expression von messenger-polycistronen
EP4522181A4 (de) Verwendung von natriumpentaboratpentahydrat als chemotherapeutikum
CL2025002125A1 (es) Compuestos novedosos
EP4305043A4 (de) Reinigung von sialooligosacchariden
EP4349335A4 (de) Verwendung von 5-nitro-8-hydroxychinolin
EP4118639A4 (de) Farbwechsel von informationselementen
EP4446313A4 (de) Hydratkristall von 5-chlor-4-(3-chlor-4-methylphenyl)-1h-imidazol-2-carbonitril
JP1741052S (ja) 腕時計用文字盤
EP4525905A4 (de) Intranasale verabreichung von polysulfid
JP1763452S (ja) 時計用文字盤
EP4189080A4 (de) Varianten von cas-nuklease
JP1736580S (ja) 時計用文字盤
EP4312666C0 (de) Kontinuierliche herstellung von taschenfedern
EP4229898C0 (de) Verwaltung der uplink-übertragung von benutzerdaten
EP4395693C0 (de) Kompensation von abweichungen mittels simulation einer fertigung
EP4293192C0 (de) Bereitstellung von steuerinformationen
EP4112597A4 (de) Stabilisierung von polysulfid

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20260316

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/22 20060101AFI20260310BHEP

Ipc: A61P 35/00 20060101ALI20260310BHEP